Log in to save to my catalogue

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosu...

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b8efdbe5c634d4ea13665c983be4fa5

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

About this item

Full title

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

Publisher

England: Lupus Foundation of America

Journal title

Lupus science & medicine, 2020-06, Vol.7 (1), p.e000375

Language

English

Formats

Publication information

Publisher

England: Lupus Foundation of America

More information

Scope and Contents

Contents

ObjectiveFas/Fas ligand (FasL) and B cell-activating factor (BAFF) signalling have pivotal roles in SLE pathogenesis. We investigated the clinical associations of serum concentrations of soluble Fas (sFas) and soluble FasL (sFasL) in SLE and their relationship with BAFF.MethodsSerum sFas and sFasL were quantified by multiplex assay, and BAFF by ELI...

Alternative Titles

Full title

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b8efdbe5c634d4ea13665c983be4fa5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b8efdbe5c634d4ea13665c983be4fa5

Other Identifiers

ISSN

2053-8790

E-ISSN

2053-8790

DOI

10.1136/lupus-2019-000375

How to access this item